Literature DB >> 28868954

Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.

Mareike Frick1,2, Marcus Bettstetter3, Simone Bertz4, Stephan Schwarz-Furlan4,5, Arndt Hartmann4, Thomas Richter6, Dido Lenze7, Michael Hummel7, Martin Dreyling8, Georg Lenz9,10, Andreas Gaumann5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28868954     DOI： 10.1080/10428194.2017.1370546

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

Review 1.  Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.

Authors:  Thomas A Ollila; Adam J Olszewski
Journal:  Curr Treat Options Oncol       Date:  2018-06-21

2.  PD-L1+ tumor-associated macrophages and PD-1+ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma.

Authors:  Marjukka Pollari; Oscar Brück; Teijo Pellinen; Pauli Vähämurto; Marja-Liisa Karjalainen-Lindsberg; Susanna Mannisto; Olli Kallioniemi; Pirkko-Liisa Kellokumpu-Lehtinen; Satu Mustjoki; Suvi-Katri Leivonen; Sirpa Leppä
Journal:  Haematologica       Date:  2018-07-19       Impact factor: 9.941

Review 3.  MYD88L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy.

Authors:  Rongrong Chen; Lulu Wang; Lixia Zhu; Xiujin Ye
Journal:  Ther Adv Hematol       Date:  2022-01-31

4.  Prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients - an immunohistochemical study.

Authors:  Asmaa Hussein Mohamed; Mariem A Elfeky; Shereen Elshorbagy; Nabila Hefzi; Tamer Oraby; Waleed A Abdelhady; Mahmoud Sharaf Eldein; Ahmed Embaby; Ehab M Oraby
Journal:  Contemp Oncol (Pozn)       Date:  2022-03-30

5.  Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma.

Authors:  Shan-Shan Li; Xiao-Hui Zhai; Hai-Ling Liu; Ting-Zhi Liu; Tai-Yuan Cao; Dong-Mei Chen; Le-Xin Xiao; Xiao-Qin Gan; Ke Cheng; Wan-Jia Hong; Yan Huang; Yi-Fan Lian; Jian Xiao
Journal:  Exp Hematol Oncol       Date:  2022-10-15

6.  Prognostic value of MYD88 L265P mutation in diffuse large B cell lymphoma via droplet digital PCR.

Authors:  Jing Niu; Zhiping Ma; Aijiang Nuerlan; Sijing Li; Wenli Cui; Haixia Gao; Gulinaer Abulajiang; Wei Zhang; Xinxia Li
Journal:  Mol Med Rep       Date:  2020-05-27       Impact factor: 2.952
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.